US.MCK · McKesson Corporation

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.393291030240258,
        "turnoverUsdM": 783.486096888,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.MCK",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 839.3158,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 4.8,
      "take_profit_price": 925.5855,
      "target_multiplier": 1.9,
      "technical_strength": 1.58,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.786582060480516,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 53.7,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 49.7,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 4
  },
  "market": {
    "ma20": 884.919,
    "ma50": 857.4148,
    "close": 881.51,
    "prevClose": 880.86,
    "avgVolume20": 894390,
    "volumeRatio": 0.99,
    "changePercent": 0.07
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 4,
    "details": {
      "ret_5d": -0.043272037595780244,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 4,
      "vcp_bonus": 0,
      "vol_ratio": 0.9880331048895855,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.9634577734104327,
      "volat_points": 0,
      "day_range_pct": 0.022245895993852714,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 53.7,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 72,
        "contribution": 3.6
      },
      {
        "raw": 6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 9.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 65.33,
        "contribution": 9.8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 16.9,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 56.33,
        "contribution": 16.9
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 49.7,
    "details": [
      "基本面分析總分: 3.6/5分",
      "資金流分析總分: 6/20分",
      "市場環境分析總分: 9.8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 16.9/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.6,
      "資金流": 6,
      "市場環境": 9.8,
      "情緒分析": 4,
      "技術信號": 16.9,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.4,
          "epsPoints": 0.75,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 783.486096888,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.MCK",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 17.84
            }
          },
          "trend": {
            "score": 2.8,
            "details": {
              "qqq": {
                "ma20": 715.6679992,
                "ma50": 710.4063990999997,
                "name": "QQQ",
                "close": 714.88,
                "points": 1.4
              },
              "spy": {
                "ma20": 766.87899445,
                "ma50": 758.61640102,
                "name": "SPY",
                "close": 764.28998,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.393291030240258,
          "atrPoints": 3,
          "cciPoints": 1.6,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142067334,
                "url": "https://finnhub.io/api/news?id=c0acbb5341553aa754e7b05905d53396d38f96fa91222d73ec5bc641c41c6ee1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) closed at $880.86 in the latest trading session, marking a -1.21% move from the prior day.",
                "category": "company",
                "datetime": 1789077605,
                "headline": "McKesson (MCK) Suffers a Larger Drop Than the General Market: Key Insights"
              },
              {
                "id": 142024856,
                "url": "https://finnhub.io/api/news?id=fdc43e5ec4ba34605b1cb41f008eaddf49644481fa8eafdae01168b12a3c2d1e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
                "category": "company",
                "datetime": 1788958804,
                "headline": "McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It"
              },
              {
                "id": 141949426,
                "url": "https://finnhub.io/api/news?id=a31af409867bcaa71974fe4e8d7bf4b7e6c90421c76a5629c04f971119f24b07",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "McKesson Corporation (MCK) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 8:00 AM EDTCompany ParticipantsKenny Cheung - Executive VP &...",
                "category": "company",
                "datetime": 1788864352,
                "headline": "McKesson Corporation (MCK) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141437664,
                "url": "https://finnhub.io/api/news?id=3357c2f285bd11902a992ee033011f12209873b2e3e36a0b5a1c42f5be967018",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788535831,
                "headline": "Why Is McKesson (MCK) Up 5.7% Since Last Earnings Report?"
              },
              {
                "id": 141455245,
                "url": "https://finnhub.io/api/news?id=dd156e46da0fd830ecf192501040ce786d5f1158745241229cfb61def8709aa7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson has outpaced the healthcare sector, and analysts remain highly optimistic about the stock’s outlook.",
                "category": "company",
                "datetime": 1788525784,
                "headline": "McKesson Stock: Is MCK Outperforming the Healthcare Sector?"
              },
              {
                "id": 141362484,
                "url": "https://finnhub.io/api/news?id=42a808ca6565b338678350b3fd37bbec66952747baaad7bca11942fce2cc3284",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson Corporation (NYSE:MCK) has agreed to acquire privately held Precision Medicine Group for approximately $2.25 billion, as the healthcare company continues shifting its portfolio toward higher-growth businesses. Precision Medicine provides clinical research, laboratory testing, and commercialization services to biotechnology and pharmaceutical companies developing and launching new medicines. McKesson plans to integrate the company into its […]",
                "category": "company",
                "datetime": 1787977965,
                "headline": "McKesson Corporation (MCK) Doubles Down on Healthcare Growth With Precision Medicine Acquisition"
              },
              {
                "id": 141362485,
                "url": "https://finnhub.io/api/news?id=e47f723e4ec811f4f889f00701e1a45f0651849549dc22c3af7995545000aa1f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) announced an agreement to acquire Precision Medicine Group to expand its oncology and clinical research services. The deal is aimed at deepening McKesson's role in personalized medicine and specialty care, particularly in oncology and biopharma clinical trial support. The acquisition is expected to reshape McKesson's service mix across oncology practices, biopharma partners and clinical research organizations. For readers looking beyond McKesson to other potential...",
                "category": "company",
                "datetime": 1787865406,
                "headline": "What Does McKesson (MCK) Gain From Its Push Into Oncology And Clinical Research?"
              },
              {
                "id": 141279873,
                "url": "https://finnhub.io/api/news?id=3767b39289f961b23b4cea0a3fc907e9f9236de7fa29f9ab8b87d5a591e7449f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson stock has delivered a very strong 336.0% return over the past five years, yet the current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) model both still point to the shares trading below their estimated worth. Over 5 years, McKesson has returned 336.0%, which puts recent share price moves in the context of a long and very strong run. Expectations for McKesson's ability to keep converting revenue into reliable cash flows can support the...",
                "category": "company",
                "datetime": 1787275175,
                "headline": "McKesson (MCK) Stock May Trade At A Discount As Cash Flow Holds Up"
              }
            ],
            "raw_source": [
              {
                "id": 142089518,
                "url": "https://finnhub.io/api/news?id=2b34a2a5a93661fb44b03a5ae23beb9474b495656e1ceef30023166f3e89facb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.",
                "category": "company",
                "datetime": 1789150860,
                "headline": "CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?"
              },
              {
                "id": 142087142,
                "url": "https://finnhub.io/api/news?id=d6d0c72b86d9e618670b0425256ff71064320995e71838714d702775481e1376",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Amgen is profitable and paying a growing dividend, while Revolution Medicines is burning cash to fund what could be one of the most important cancer drug launches in years.",
                "category": "company",
                "datetime": 1789141777,
                "headline": "Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142087143,
                "url": "https://finnhub.io/api/news?id=76d994f26a70f0f9c15f617bc2f51be0a2aaee74fdcd41e930440fc7f064cf70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how diseases are treated.",
                "category": "company",
                "datetime": 1789140567,
                "headline": "Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142067334,
                "url": "https://finnhub.io/api/news?id=c0acbb5341553aa754e7b05905d53396d38f96fa91222d73ec5bc641c41c6ee1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) closed at $880.86 in the latest trading session, marking a -1.21% move from the prior day.",
                "category": "company",
                "datetime": 1789077605,
                "headline": "McKesson (MCK) Suffers a Larger Drop Than the General Market: Key Insights"
              },
              {
                "id": 142063302,
                "url": "https://finnhub.io/api/news?id=ad181144a7d06182ba609e0908d03dc6ded85f4ed97764dbd7f7ce1ac0017980",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie's diversified portfolio faces patent headwinds, while Novo Nordisk dominates a faster-growing market, but one trades at a steeper valuation.",
                "category": "company",
                "datetime": 1789062373,
                "headline": "AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142063354,
                "url": "https://finnhub.io/api/news?id=048a492322933b269d7e80caf13a16d0fcc27cc8948d27855f206759fbc84081",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Amgen trades at a fraction of Moderna's valuation, but one company is burning cash while the other generates billions, a critical divide for income-focused investors.",
                "category": "company",
                "datetime": 1789057284,
                "headline": "Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142062044,
                "url": "https://finnhub.io/api/news?id=560137700fdb0274b2b3959c029fe5878e28a09596be394126c5f9b6d5d4d425",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1789054203,
                "headline": "Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 142056230,
                "url": "https://finnhub.io/api/news?id=89cb57547d412435307bb9f21f5d4dfe69480622ee86b74a472f5db60470e660",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1309251202/image_1309251202.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "The largest positive contributors included Seagate, Micron, and Taiwan Semiconductor. Read more here.",
                "category": "company",
                "datetime": 1789021800,
                "headline": "Janus Henderson Global Sustainable Equity (ADR) Managed Account Q2 2026 Portfolio Update"
              },
              {
                "id": 142024856,
                "url": "https://finnhub.io/api/news?id=fdc43e5ec4ba34605b1cb41f008eaddf49644481fa8eafdae01168b12a3c2d1e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
                "category": "company",
                "datetime": 1788958804,
                "headline": "McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It"
              },
              {
                "id": 142024857,
                "url": "https://finnhub.io/api/news?id=24b6718bedd1e62e047e22a7dd80db0667efcdb5adbe49ba4fa336e63fe9f492",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "SEATTLE, September 09, 2026--Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, is pleased to announce that Tom Rodgers will join the firm as a Senior Partner in October 2026. In this role, Mr. Rodgers will partner with Frazier’s Growth Buyout deal teams, providing strategic counsel on investment evaluation, portfolio value creation, and sector-level insights informed by more than 35 years of experience in healthcare strategy, corporate development",
                "category": "company",
                "datetime": 1788955200,
                "headline": "Frazier Healthcare Partners Welcomes Tom Rodgers as Senior Partner"
              },
              {
                "id": 141952689,
                "url": "https://finnhub.io/api/news?id=b4df56d6015169489daf46666a01566f77be8ab57d8d5bfde1d18d2e1638dc87",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.",
                "category": "company",
                "datetime": 1788886998,
                "headline": "3 Market-Beating Stocks for Long-Term Investors"
              },
              {
                "id": 141950716,
                "url": "https://finnhub.io/api/news?id=8483fa41d6072ee44cea77dcbda0a547cebf1d856a602d91d28e799874c7640c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) discussed its planned $2.25 billion acquisition of Precision Medicine Group, first-quarter operating trends and capital-allocation priorities during a presentation with Wells Fargo analyst Stephen Baxter. The company said Precision Medicine Group would expand two areas it has id",
                "category": "company",
                "datetime": 1788872528,
                "headline": "McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates"
              },
              {
                "id": 141950717,
                "url": "https://finnhub.io/api/news?id=849bf6844aa6949a68d02d3ef7ff13a7c0b6166e85f0e4c74feecce7b70a04b0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "CHICAGO, September 08, 2026--Shore Capital Partners (\"Shore\" or \"Shore Capital\"), a Chicago-based private equity firm with an office in Nashville, today announced that Tommy Pourmahram has been named Chief Executive Officer of Reliant Infusion, a Shore portfolio company and provider of specialty infusion services.",
                "category": "company",
                "datetime": 1788872400,
                "headline": "Reliant Infusion Names Tommy Pourmahram Chief Executive Officer"
              },
              {
                "id": 141949426,
                "url": "https://finnhub.io/api/news?id=a31af409867bcaa71974fe4e8d7bf4b7e6c90421c76a5629c04f971119f24b07",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "McKesson Corporation (MCK) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 8:00 AM EDTCompany ParticipantsKenny Cheung - Executive VP &...",
                "category": "company",
                "datetime": 1788864352,
                "headline": "McKesson Corporation (MCK) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141808253,
                "url": "https://finnhub.io/api/news?id=83dffed7de3f2b65ec0363da9b401d307f735e8a5b9dc4236e3023551fd7192c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/942145090/image_942145090.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "McKesson operates within a US pharma distribution oligopoly, generating $5B+ in FCF and aggressively repurchasing shares. See why I rate MCK stock a Buy.",
                "category": "company",
                "datetime": 1788833333,
                "headline": "Underestimating The Moat: Why McKesson's Oncology Pivot And Share Buybacks Signal Structural Upside"
              },
              {
                "id": 141765194,
                "url": "https://finnhub.io/api/news?id=6aa53833c6e108cbd1eac942a34ce50a40cb1ebda0d60db67ea6cdcd204a6962",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "CVS Health is advancing Aetna's profitability turnaround, supported by stronger Health Care Benefits results, an improved MBR and operational initiatives.",
                "category": "company",
                "datetime": 1788796200,
                "headline": "Here's How CVS Is Focusing on Aetna's Profitability Turnaround"
              },
              {
                "id": 141593755,
                "url": "https://finnhub.io/api/news?id=86f8969ab47c49412072028654335b4ce82e4065a7327a97008c027d9ebdde4c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Reuters reported that McKesson Corporation (NYSE:MCK) said it would buy privately held Precision Medicine Group in a deal valued at about $2.25 billion as part of a “years-long effort to strengthen its higher-growth businesses.” McKesson has been reshaping its portfolio by exiting non-core assets and streamlining its operations while investing in businesses such as oncology […]",
                "category": "company",
                "datetime": 1788731019,
                "headline": "McKesson Bets $2.25 Billion More on Oncology With Precision Medicine Buy"
              },
              {
                "id": 141455037,
                "url": "https://finnhub.io/api/news?id=882e78db4092ee8e4a4f8c9153c570608198427b13f54f3413147816ac706bb2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie's immunology pivot is offsetting Humira's decline, while Pfizer trades at half the valuation despite patent risks ahead.",
                "category": "company",
                "datetime": 1788547801,
                "headline": "AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141437664,
                "url": "https://finnhub.io/api/news?id=3357c2f285bd11902a992ee033011f12209873b2e3e36a0b5a1c42f5be967018",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788535831,
                "headline": "Why Is McKesson (MCK) Up 5.7% Since Last Earnings Report?"
              },
              {
                "id": 141455245,
                "url": "https://finnhub.io/api/news?id=dd156e46da0fd830ecf192501040ce786d5f1158745241229cfb61def8709aa7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson has outpaced the healthcare sector, and analysts remain highly optimistic about the stock’s outlook.",
                "category": "company",
                "datetime": 1788525784,
                "headline": "McKesson Stock: Is MCK Outperforming the Healthcare Sector?"
              },
              {
                "id": 141446166,
                "url": "https://finnhub.io/api/news?id=2c89c2975d89a1f9f49ebd0e30276c2f76bd6a4d77b88da08d663e5f5ac92c62",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/insider_trade_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "A September filing shows that Representative Jonathan Jackson reported a sale in Viasat (NASDAQ:VSAT), valued between $1,001 and $15,000. The transaction date is listed as August 28, 2026, with the report published on",
                "category": "company",
                "datetime": 1788519613,
                "headline": "A Congress Member Sold Up To $15K In Viasat Stock: Here's What You Need To Know"
              },
              {
                "id": 141406350,
                "url": "https://finnhub.io/api/news?id=7f06d643160898f1cbdc391a8a9105109c98cd0a5edf1bf978d1a4c97a7e8a62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "On the September 2 episode of Mad Money, Jim Cramer called Cardinal Health, Inc. (NYSE:CAH) one of his “absolute favorites” and mentioned its growing exposure to specialty pharmaceuticals and higher-margin healthcare services. Cardinal’s been running circles around McKesson and Cencora. They consistently put up the best numbers because this company has gradually become less of […]",
                "category": "company",
                "datetime": 1788472375,
                "headline": "Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore”"
              },
              {
                "id": 141403880,
                "url": "https://finnhub.io/api/news?id=2e84096df15ac30b56cad9794a7c930f96ca0a6d437a48ac470b179160eb83fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth despite mix, pricing and financing pressures.",
                "category": "company",
                "datetime": 1788463320,
                "headline": "Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen"
              },
              {
                "id": 141398251,
                "url": "https://finnhub.io/api/news?id=328a82c3d457909e88b69b893d71448dd5d5c025b99eb4233343050a4eaa9df2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cardinal Health's generic volumes, profitable brand-to-generic conversions and Red Oak program continue to support Pharma profits.",
                "category": "company",
                "datetime": 1788441720,
                "headline": "Is Generics Still a Quiet Profit Engine for Cardinal Health?"
              },
              {
                "id": 141379924,
                "url": "https://finnhub.io/api/news?id=6afcece2c335857767d8a7dc325db935366d73038876930ff1f2cb2b051c6760",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The healthcare distributor said the incident affected a subset of customers in its oncology and medical-surgical businesses.",
                "category": "company",
                "datetime": 1788349876,
                "headline": "McKesson confirms data theft in cyberattack involving third-party apps"
              },
              {
                "id": 141362499,
                "url": "https://finnhub.io/api/news?id=5c7d450744a64abf76b03d01f59feaa6a0193540e5b8b10958925600f68cc7eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
                "category": "company",
                "datetime": 1788269402,
                "headline": "Here's How Much a $1000 Investment in McKesson Made 10 Years Ago Would Be Worth Today"
              },
              {
                "id": 141348564,
                "url": "https://finnhub.io/api/news?id=7009d4f82a8712cebfa86427db9a724d72e0b2b5febcd81764d5d26f56545d3b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.",
                "category": "company",
                "datetime": 1788028861,
                "headline": "AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141361438,
                "url": "https://finnhub.io/api/news?id=940a43f5ddc818d2bd608a743ecdb586ed6fb5e91ade75734e7d1edb77b505aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.",
                "category": "company",
                "datetime": 1788023101,
                "headline": "Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141362484,
                "url": "https://finnhub.io/api/news?id=42a808ca6565b338678350b3fd37bbec66952747baaad7bca11942fce2cc3284",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson Corporation (NYSE:MCK) has agreed to acquire privately held Precision Medicine Group for approximately $2.25 billion, as the healthcare company continues shifting its portfolio toward higher-growth businesses. Precision Medicine provides clinical research, laboratory testing, and commercialization services to biotechnology and pharmaceutical companies developing and launching new medicines. McKesson plans to integrate the company into its […]",
                "category": "company",
                "datetime": 1787977965,
                "headline": "McKesson Corporation (MCK) Doubles Down on Healthcare Growth With Precision Medicine Acquisition"
              },
              {
                "id": 141341224,
                "url": "https://finnhub.io/api/news?id=a70f356816315e6c1cffbf3ddb6582552dedd39464f32f29f67f627611d5c738",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "Dividend activity recap for Champions, Contenders & Challengers: dividend changes plus upcoming ex-dividend and pay dates. See more here.",
                "category": "company",
                "datetime": 1787954658,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week August 30"
              },
              {
                "id": 141345937,
                "url": "https://finnhub.io/api/news?id=9aa1b0e18be5e6d174f41bbc3dc796dcb4158949f0235d825fd43014622745c4",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "https://www.sec.gov/ix?doc=/Archives/edgar/data/0000927653/000092765326000247/mck-20260825.htm",
                "category": "company",
                "datetime": 1787933458,
                "headline": "McKesson Says It Discovered Cybersecurity Incident Affecting Its Information Systems On August 25; Investigation In Early Stages, Has Not Determined If Incident Is Material"
              },
              {
                "id": 141362485,
                "url": "https://finnhub.io/api/news?id=e47f723e4ec811f4f889f00701e1a45f0651849549dc22c3af7995545000aa1f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) announced an agreement to acquire Precision Medicine Group to expand its oncology and clinical research services. The deal is aimed at deepening McKesson's role in personalized medicine and specialty care, particularly in oncology and biopharma clinical trial support. The acquisition is expected to reshape McKesson's service mix across oncology practices, biopharma partners and clinical research organizations. For readers looking beyond McKesson to other potential...",
                "category": "company",
                "datetime": 1787865406,
                "headline": "What Does McKesson (MCK) Gain From Its Push Into Oncology And Clinical Research?"
              },
              {
                "id": 141362486,
                "url": "https://finnhub.io/api/news?id=1f989b9642ae7bee3a901cd1882915a8ee1c8ac1bcde15bfe832a682f244e6fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "DENVER, August 27, 2026--Modivcare, a leading provider of non-emergency transportation, personal care services, and monitoring solutions, announced the appointment of Matt Williams as Chief Corporate Affairs Officer, effective September 1, 2026.",
                "category": "company",
                "datetime": 1787859240,
                "headline": "Modivcare Appoints Matt Williams as Chief Corporate Affairs Officer"
              },
              {
                "id": 141338176,
                "url": "https://finnhub.io/api/news?id=87625a941bafa88d74ed14c99a4be44d2e38601a7bb34d9b743e2794daa4a3fa",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) has outperformed the market over the past 10 years by 3.54% on an annualized basis producing an average annual return of 17.04%. Currently, McKesson has a market capitalization of $103.82 billion.",
                "category": "company",
                "datetime": 1787850935,
                "headline": "Here’s How Much You Would Have Made Owning McKesson Stock In The Last 10 Years"
              },
              {
                "id": 141362487,
                "url": "https://finnhub.io/api/news?id=859e66a15a81fed71b31f1f47807c408b556a8a74534b8edfe4ea2da17ed01a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "MCK's $2.25B Precision Medicine Group deal aims to expand clinical research and commercialization services in oncology and multispecialty care.",
                "category": "company",
                "datetime": 1787847720,
                "headline": "McKesson to Acquire Precision Medicine Group to Strengthen Services"
              },
              {
                "id": 141362498,
                "url": "https://finnhub.io/api/news?id=11d84ed8bc0e1b31e4fee811e4457043fb9729476054630b1fcc47aa72df7e8b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "A real-world study suggests Zepbound use could reduce the rates of hospital stays and ER visits. Elsewhere, McKesson sprung for a multibillion-dollar deal and J&J nabbed a noteworthy approval.",
                "category": "company",
                "datetime": 1787742695,
                "headline": "Zepbound may cut healthcare costs, study says; Summit, Akeso drug hits in another China trial"
              },
              {
                "id": 141362488,
                "url": "https://finnhub.io/api/news?id=db0403d82390c00d8bcdfd1c1a92e2a7f3c4b8870698d860d52cf130d97c3259",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson believes that the deal will support its clinical research and biopharmaceutical commercialisation services.",
                "category": "company",
                "datetime": 1787741174,
                "headline": "McKesson to acquire Precision Medicine Group for $2.25bn"
              },
              {
                "id": 141362489,
                "url": "https://finnhub.io/api/news?id=8fea69045a18763479a2d565ca9a79326b7d37506435edfef369512728d3186a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Healthcare stocks rose late Tuesday afternoon with the NYSE Healthcare Index and the State Street He",
                "category": "company",
                "datetime": 1787691435,
                "headline": "Sector Update: Healthcare Stocks Advance Late Afternoon"
              },
              {
                "id": 141362490,
                "url": "https://finnhub.io/api/news?id=61f1e295314b78b284effd3ecf0f2a180194ab0bb8668aa49d6383a463f2b73c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The drug distributor will fold the clinical research and biopharma commercialization firm into its oncology unit once the deal closes",
                "category": "company",
                "datetime": 1787683713,
                "headline": "McKesson to acquire Precision Medicine Group for $2.25 billion"
              },
              {
                "id": 141362500,
                "url": "https://finnhub.io/api/news?id=c97396ca69cebd061cfc6360bafae78a6e230404b8a15b7da204581678be53e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "MCK's specialty distribution, oncology and technology businesses are fueling growth, while drug-pricing pressure and policy shifts pose risks.",
                "category": "company",
                "datetime": 1787677260,
                "headline": "Here's Why You Should Retain McKesson Stock in Your Portfolio for Now"
              },
              {
                "id": 141362491,
                "url": "https://finnhub.io/api/news?id=d01bee3895bd2a8a8fc9cfa10de581da43b7ddb7ca5b61497c518cc26acfb2e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) has agreed to acquire Precision Medicine in a transaction worth roughly $2.25 billion",
                "category": "company",
                "datetime": 1787676455,
                "headline": "McKesson to Buy Precision Medicine in $2.25 Billion Deal"
              },
              {
                "id": 141362492,
                "url": "https://finnhub.io/api/news?id=41c37e829247116594950d3dff826f9f47e0a213a986e3946b0f02205ba92f60",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson Corporation (NYSE:MCK) on Tuesday announced an agreement to acquire Precision Medicine Group.The deal provides McKesson with an opportunity to expand its clinical research and commercialization services.McKesson will acquire Precision Medicine Group for approximately $2.25 billion.Following completion of the transaction, Precision Medicine Group will report within McKesson’s Oncology & Multispecialty segment, its second-largest segment with first-quarter sales of $14.2 billion.McKesson",
                "category": "company",
                "datetime": 1787675476,
                "headline": "McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization"
              },
              {
                "id": 141362501,
                "url": "https://finnhub.io/api/news?id=d03ba15a1e976178b96d4c3b5e2f8f16838c6e7ed3212d968bc5a3a7a88eebc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "IRVING, Texas, August 25, 2026--McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC (\"Precision Medicine Group\"), a global provider of clinical research and biopharma commercialization services.",
                "category": "company",
                "datetime": 1787662800,
                "headline": "McKesson Signs Agreement to Acquire Precision Medicine Group, LLC"
              },
              {
                "id": 141362494,
                "url": "https://finnhub.io/api/news?id=813bbe30273839d5c9e39751e4840e5380adf79983ce68785f5bc9d92a450f8a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson raises fiscal 2027 EPS guidance as oncology, GLP-1 volumes and specialty distribution drive faster profit growth despite cash-flow pressure.",
                "category": "company",
                "datetime": 1787600940,
                "headline": "McKesson Raises FY27 Guidance as Oncology and GLP-1 Growth Accelerate"
              },
              {
                "id": 141362493,
                "url": "https://finnhub.io/api/news?id=a26caf7ebd42adc41c28417195d15ca548d9f7918e53a2033fe7bbaeb5ef1826",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson's double-digit earnings growth, specialty expansion and capital returns support the story, but a premium valuation leaves less room for error.",
                "category": "company",
                "datetime": 1787600940,
                "headline": "Is McKesson Stock Worth Buying as Growth Meets a Premium Valuation?"
              },
              {
                "id": 141362495,
                "url": "https://finnhub.io/api/news?id=249f65582612259e488427d63d20ac05971ace8e805a5df53806a2ad89edea44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1787585960,
                "headline": "McKesson Stock Outlook: Is Wall Street Bullish or Bearish?"
              },
              {
                "id": 141279873,
                "url": "https://finnhub.io/api/news?id=3767b39289f961b23b4cea0a3fc907e9f9236de7fa29f9ab8b87d5a591e7449f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson stock has delivered a very strong 336.0% return over the past five years, yet the current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) model both still point to the shares trading below their estimated worth. Over 5 years, McKesson has returned 336.0%, which puts recent share price moves in the context of a long and very strong run. Expectations for McKesson's ability to keep converting revenue into reliable cash flows can support the...",
                "category": "company",
                "datetime": 1787275175,
                "headline": "McKesson (MCK) Stock May Trade At A Discount As Cash Flow Holds Up"
              },
              {
                "id": 141279875,
                "url": "https://finnhub.io/api/news?id=f6035c2fee2c59ca1eaac8e5da967b709784076bca00286133a3da05dae0cb0b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) is in focus after its technology leadership team joined the 17th Annual Atlanta C-Level Technology Leadership Summit, highlighting how its healthcare technology services fit alongside recent quarterly results and the current stock performance. See our latest analysis for McKesson. At a share price of $853.71, McKesson has eased slightly in the very short term, with a 1-day share price return that declined 1.79% and a 7-day share price return that declined 2.85%. However, its...",
                "category": "company",
                "datetime": 1787256543,
                "headline": "McKesson (MCK) Joined A Tech Summit, Is It Still 13% Undervalued?"
              },
              {
                "id": 141261329,
                "url": "https://finnhub.io/api/news?id=0bcc4b756c6d1ebb9c1d9f3ee76fbdf22f5f0eca89a7e45fd098bfb7d6ddce91",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157585497/image_2157585497.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "Net of fees, GRW delivered a return of +17.32% in Q2 2026, compared to the S&P 500 Index's return of +15.20%.",
                "category": "company",
                "datetime": 1787217000,
                "headline": "TCW Durable Growth ETF Q2 2026 Performance Update"
              },
              {
                "id": 141258800,
                "url": "https://finnhub.io/api/news?id=bdb7e234a55d9cb334bafa47adbce8dc37ba2ded4a75ace86531b8150354fc20",
                "image": "",
                "source": "Fintel",
                "related": "MCK",
                "summary": "",
                "category": "company",
                "datetime": 1787190141,
                "headline": "RBC Capital Initiates Coverage of McKesson (MCK) with Sector Perform Recommendation"
              },
              {
                "id": 141279876,
                "url": "https://finnhub.io/api/news?id=80e2683d6b03e9856102f88928d0b33f293bf6830fce12c7e49c75c925df79ae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Henry Schein's broader growth, recurring technology revenues and savings plan support its outlook, but leverage and execution risks remain key concerns.",
                "category": "company",
                "datetime": 1787157180,
                "headline": "Is HSIC Worth Buying as Growth Improves but Execution Risks Persist?"
              },
              {
                "id": 141255098,
                "url": "https://finnhub.io/api/news?id=407cd590acc44067e69ec21c3b5d573dbff31e348a254be4edac3e8cfcac88f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1787150302,
                "headline": "Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141279874,
                "url": "https://finnhub.io/api/news?id=71e8053143691ce56fa051f1633b66dd2fc4e0397c0f77a7befeda58c6e547db",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare providers & services stocks fared in Q2, starting with McKesson (NYSE:MCK).",
                "category": "company",
                "datetime": 1787146682,
                "headline": "Winners And Losers Of Q2: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks"
              },
              {
                "id": 141257551,
                "url": "https://finnhub.io/api/news?id=f6172b7c49124c0d4ec9fce8c5738b4d9d405e7db8353fc6b685e4509c75e306",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "Barclays  analyst Glen Santangelo   maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $925 to $1000.",
                "category": "company",
                "datetime": 1787134773,
                "headline": "Barclays Maintains Overweight on McKesson, Raises Price Target to $1000"
              },
              {
                "id": 141257552,
                "url": "https://finnhub.io/api/news?id=6be89915164eaea69f703cb5c151a416184f8f61bf8d3c61215b0822d48fd47d",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "RBC Capital  analyst Ryan Halsted   initiates coverage on McKesson (NYSE:MCK) with a Sector Perform rating and announces Price Target of $845.",
                "category": "company",
                "datetime": 1787133051,
                "headline": "RBC Capital Initiates Coverage On McKesson with Sector Perform Rating, Announces Price Target of $845"
              },
              {
                "id": 141279877,
                "url": "https://finnhub.io/api/news?id=c47505c3dc9586b3a6348210ab896b422c8c06eda61b4c18fa117bc974b4f9e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "OPK raises $125 million against mazdutide royalties, gaining non-dilutive capital while retaining longer-term royalty upside.",
                "category": "company",
                "datetime": 1787077380,
                "headline": "OPKO Health Secures $125 Million Financing Against Mazdutide Royalties"
              },
              {
                "id": 141223241,
                "url": "https://finnhub.io/api/news?id=33a2434b268e9c2c0fa89571638f2150a7ee2e9c0b89bccb945d9e3a0e34de88",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Bristol-Myers Squibb trades at less than half the valuation multiple of AbbVie, but AbbVie's revenue growth tells a different story about future earnings power.",
                "category": "company",
                "datetime": 1786740389,
                "headline": "AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141237778,
                "url": "https://finnhub.io/api/news?id=367a84c2f8076f5a8bad9804ededf729b3319df5dfda2f5bb74e17f5d37735d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.",
                "category": "company",
                "datetime": 1786725360,
                "headline": "Reasons to Hold Hinge Health Stock in Your Portfolio for Now"
              },
              {
                "id": 141237779,
                "url": "https://finnhub.io/api/news?id=e344598255c9673102ba1313d573d1c3a3aa83d0bc7043f35aeaa1663a617a7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.",
                "category": "company",
                "datetime": 1786725300,
                "headline": "SOLV Plans Health Information Systems Business Spinoff to Drive Growth"
              },
              {
                "id": 141215404,
                "url": "https://finnhub.io/api/news?id=beb9b099af96d85f171d75a1ec7e33b07f1b4f81a4d3a80843d5472a77c0205e",
                "image": "",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "",
                "category": "company",
                "datetime": 1786685700,
                "headline": "Allspring Large Cap Growth Fund Q2 2026 Performance Update"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 60,
            "discarded_article_count": 49
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 16.9,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.2,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.2,
            "vcp_reason": "波幅收縮(13.5%→6.1%)；跌縮量(近10日4日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 976920,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 901050,
              "avg_vol_20": 899565,
              "avg_vol_30": 976920,
              "range_pct_10": 0.060657314600432125,
              "range_pct_20": 0.10444579069499169,
              "range_pct_30": 0.13507505150168406,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9223375506694509,
              "dist_to_20d_high": 0.052088821419551415,
              "down_shrink_days": 4,
              "breakout_level_20d": 929.95001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.4490637902860683
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.393291030240258,
              "turnoverUsdM": 783.486096888,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.MCK",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 839.3158,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 4.8,
            "take_profit_price": 925.5855,
            "target_multiplier": 1.9,
            "technical_strength": 1.58,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.786582060480516,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 21.0971,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.39
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -7.76
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0334
    },
    "kdj": {
      "d": 44.61,
      "j": -6.17,
      "k": 27.69,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 45.42
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": -4849300,
      "recentSlope": -117370,
      "previousSlope": -51150
    },
    "rsi": 57.03,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 929.95,
      "position": "SAR喺價上",
      "distancePct": 5.5,
      "previousTrend": "上升"
    },
    "ma50": 857.4148,
    "macd": {
      "macd": 10.58867909972139,
      "trend": "中性偏多",
      "signal": 14.11748417042296,
      "histogram": -3.528805070701571
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 884.8192,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.99,
      "score": 4,
      "avgVolume": 894390,
      "currentVolume": 888800
    },
    "derived": {
      "ma20": 884.919,
      "ma50": 857.4148,
      "prevClose": 880.86,
      "avgVolume10": 879130,
      "avgVolume20": 894390,
      "changePercent": 0.07,
      "avgVolumeForScore": 894390
    },
    "ma_cross": {
      "ma20": 884.919,
      "ma50": 857.4148,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 883.678,
      "prevMa50": 855.1458,
      "spreadPct": 3.21,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 840.88,
      "upper": 928.958,
      "position": "中間"
    },
    "rsi_short": 6.46,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.99
    }
  }
}

{
  "close": 881.51,
  "volume": 888800,
  "changePercent": 0.07
}